RPL38P3

Across TCGA pan-cancer cohorts, RPL38P3 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL38P3’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL38P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL38P3 is over-expressed in tumor, although a few such as LIHC show the opposite, repressed pattern.

COAD, LUAD, and LIHC are the cancer types where RPL38P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL38P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.432	.031	2	view →
LUAD	All	III,IV	+0.212	.033	1	view →
LIHC	All	II,III,IV	−0.043	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL38P3–COAD

Open the COAD breakdown →